Crestchem FY26 Net Profit Down 59.5% to ₹1.10 Crore on Lower Income

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Crestchem FY26 Net Profit Down 59.5% to ₹1.10 Crore on Lower Income
Overview

Crestchem Limited reported a 65.46% drop in total income to ₹10.23 crore and a 59.54% fall in net profit to ₹1.10 crore for FY26. The decline reflects reduced business volume in its trading operations.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Crestchem FY26 Results Show Sharp Decline in Income and Profit

Crestchem Limited's total income from operations fell 65.46% to ₹10.23 crore, and net profit declined 59.54% to ₹1.10 crore for the year ended March 31, 2026.

Reader Takeaway: Revenue and profit contraction; focus on trading segment performance.

What just happened

Crestchem Limited announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a significant year-on-year decrease in its financial performance. Total income from operations saw a sharp decline of 65.46%, falling to ₹10.23 crore from ₹29.61 crore in the previous fiscal year. Consequently, the net profit after tax also dropped by 59.54% to ₹1.10 crore, down from ₹2.73 crore in FY25. Earnings Per Share (EPS) reflected this trend, decreasing by 59.63% to ₹3.67.

Why this matters

These results indicate a challenging period for Crestchem, marked by a substantial reduction in business volume. The steep fall in both revenue and profitability directly impacts shareholder value and raises questions about the company's operational effectiveness and market position within its trading segment. Investors will closely monitor management's strategy to address this downturn.

The backstory

Crestchem Limited operates primarily in the trading segment. The reported financials are consolidated, including the operations of its subsidiary, The Ocean Bio Science Private Limited. The previous fiscal year, FY25, showed a higher income of ₹29.61 crore and a net profit of ₹2.73 crore.

What changes now

The audited results provide a clear picture of the company's performance for FY26. While the numbers confirm a contraction, they also serve as a baseline for future performance. Investors will be looking for signs of recovery or strategic shifts in upcoming quarters.

Risks to watch

The primary risk lies in the company's single-segment focus on trading, making it vulnerable to market fluctuations and intense competition. The significant decline in FY26 highlights the sensitivity of its business model to economic conditions and demand.

Peer comparison

(Information not available in the filing for peer comparison).

Context metrics (time-bound)

  • Total Income (FY26): ₹10.23 crore
  • Net Profit (FY26): ₹1.10 crore
  • EPS (FY26): ₹3.67
  • Year-on-Year Income Change: -65.46%
  • Year-on-Year Profit Change: -59.54%

What to track next

Investors should track the company's commentary on the reasons for the decline, any new business strategies or diversification plans, and performance in the upcoming quarters, especially concerning the trading segment and subsidiary operations.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.